Plair raises CHF 1 M

Plair sells RAPID-C+, a real-time viable particle counter for monitoring pharmaceutical cleanrooms. bioMérieux is investing more than CHF 1 million in the Geneva scale-up and taking a seat on its board.

Announced on
Round
Undisclosed round
Amount
CHF 1 M
Location
Geneva
Sector
Health & medtech

Investors

  • bioMérieux

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic